ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
Phaedrus
|
38 |
20K |
26 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
20K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
Phaedrus
|
38 |
20K |
30 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
20K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
18K |
7.1M |
21 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
18K
|
7.1M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Phaedrus
|
549 |
190K |
8 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
549
|
190K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
53K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Phaedrus
|
1.0K |
453K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.0K
|
453K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
53K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
55 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
53K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
15 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
53K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
53K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Phaedrus
|
549 |
190K |
20 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
549
|
190K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
45 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
53K
|
45
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
133 |
53K |
35 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
53K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
867 |
399K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
867
|
399K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
21 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
5 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
943 |
417K |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
943
|
417K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
943 |
417K |
14 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
943
|
417K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
943 |
417K |
15 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
943
|
417K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
943 |
417K |
16 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
943
|
417K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Phaedrus
|
943 |
417K |
36 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
943
|
417K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
15 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
8 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
13 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
12K |
3.9M |
12 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
12K
|
3.9M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Newsflow & Re-rate Estimations
|
|
Phaedrus
|
52 |
25K |
53 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
52
|
25K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Newsflow & Re-rate Estimations
|
|
Phaedrus
|
52 |
25K |
23 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
52
|
25K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Phaedrus
|
116 |
46K |
21 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
46K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Phaedrus
|
116 |
46K |
9 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
46K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Phaedrus
|
116 |
46K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
46K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
18K |
7.1M |
11 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
18K
|
7.1M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
274 |
112K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
274
|
112K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Phaedrus
|
671 |
250K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
671
|
250K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
274 |
112K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
274
|
112K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
88 |
42K |
17 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
42K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Phaedrus
|
88 |
42K |
42 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
42K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Phaedrus
|
1.0K |
453K |
12 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.0K
|
453K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
18K |
7.1M |
6 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
18K
|
7.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
18K |
7.1M |
9 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
18K
|
7.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
How to Loan out shares on ASX??
|
|
Phaedrus
|
30 |
9.7K |
18 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
30
|
9.7K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
867 |
399K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
867
|
399K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
867 |
399K |
19 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
867
|
399K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Phaedrus
|
867 |
399K |
3 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
867
|
399K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Phaedrus
|
277 |
135K |
34 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
277
|
135K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
18K |
7.1M |
7 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
18K
|
7.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Phaedrus
|
6.0K |
3.0M |
4 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
6.0K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
274 |
112K |
5 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
274
|
112K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
274 |
112K |
11 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
274
|
112K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Phaedrus
|
274 |
112K |
36 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
274
|
112K
|
36
|
|